Clinical Trial Update: Prospective Clinical Study to Identify Secondary Sentinel Lymph Nodes in Patients With N1/N2b Oral Cavity or H&N Skin Cancers Using Patent Blue V and Indocyanine Green Dyes [Phase 2]

View source ↗

Summary

A Phase 2 prospective clinical study to identify secondary sentinel lymph nodes in patients with oral cavity cancer or head and neck cancer, using Patent Blue V…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oral Cavity Cancer

Drugs mentioned

• Indocyanine Green (Indocyanine Green)
• Patent Blue V (isosulfan blue)

Snippet

Sponsor: Centre Hospitalier Universitaire Vaudois | Conditions: N1/N2b Oral Cavity Cancer, Head and Neck Skin Cancer | Phase 2 | Status: NOT_YET_RECRUITING